Belgian centre rules on multibillion pharma fraud claim
A US pharmaceutical company says it has prevailed in what is thought to be the largest-ever case heard at Belgian arbitral institution CEPANI, concerning alleged fraud during a US$4.3 billion acquisition.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10